Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics or …

Recent studies have provided insights into the pathogenesis of coronavirus disease 2019 (COVID-19)
1 , 2 , 3 – 4 . However, the longitudinal immunological correlates of disease …

There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more severe
symptoms and higher mortality among men than among women 1 , 2 , 3 , 4 – 5 . However…

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …

The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies
the critical need for accurate and rapid diagnostic assays to prompt clinical and public …

Recent studies have provided insights into innate and adaptive immune dynamics in
coronavirus disease 2019 (COVID-19). However, the exact features of antibody responses that …

Eukaryotic mRNA 3-end processing is a multi-step process beginning with pre-mRNA transcript
cleavage followed by poly(A) tail addition. Closely coupled to transcription termination, 3-…

Background Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to
be plagued by assay costs and supply chain shortages. In response, we developed …

Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing
COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR …

While several clinical and immunological parameters correlate with disease severity and
mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of …